Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Muyibat Adelani

Adult Reconstructive Orthopaedic Surgery Saint Louis, MO Medical Doctor

NPI 1396908042 CMS profile 1200121

4921 Parkview Pl, Ste 6A/6B/12A, Saint Louis, MO 63110

Open in the dashboard

General payments

$71,086

186 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Muyibat Adelani of Saint Louis, MO is reported in the CMS Open Payments database as having received $71,086 across 186 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,390 39
2024 General $24,295 44
2023 General $3,026 24
2022 General $17,201 35
2021 General $2,544 29
2019 General $630 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Muyibat Adelani
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Muyibat Adelani were reported at $23,390. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Muyibat Adelani Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $630 $1,416 $292–$9,336 $163
2020 $0 $647 $141–$6,474 $114
2021 $2,544 $1,073 $211–$6,497 $132
2022 $17,201 $1,217 $236–$6,299 $149
2023 $3,026 $1,082 $246–$6,818 $160
2024 $24,295 $1,575 $323–$8,944 $164
2025 $23,390 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $53,135 122 payments
  2. Medical Device Business Services, Inc. $15,403 18 payments
  3. Zimmer Biomet Holdings, Inc. $2,050 37 payments
  4. Elite Orthopedics, LLC $138 2 payments
  5. Smith+Nephew, Inc. $124 2 payments
  6. DePuy Synthes Sales Inc. $96 1 payment
  7. MicroPort Orthopedics Inc $68 1 payment
  8. Heraeus Medical, LLC. $56 2 payments
  9. Encore Medical, LP $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $53,547 25 payments
  2. Travel and Lodging $11,683 48 payments
  3. Food and Beverage $5,809 112 payments
  4. Gift $48 1 payment
Products named General payments · program years 2019–2025
  1. TRIATHLON $36,403 46 payments
  2. MAKO $35,468 83 payments
  3. INSIGNIA $25,133 15 payments
  4. ACCOLADE $10,550 6 payments
  5. GMRS $10,040 4 payments
  6. TRITANIUM $7,837 3 payments
  7. Hips-None $1,545 23 payments
  8. ATTUNE $1,029 5 payments
  9. AEQUALIS $800 1 payment
  10. Endurance $431 4 payments
  11. Other $1,115 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

481

Median for Orthopedic Surgery: 203

Drug cost

$4,028

Median for Orthopedic Surgery: $1,433

Branded share of claims

15.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 117 $961
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 76 $867
Celecoxib Generic 23 $843
Meloxicam Generic 127 $507
Ibuprofen Generic 27 $469
Tramadol Hcl Generic 39 $170
Diclofenac Sodium Generic 18 $158
Amoxicillin Generic 43 $48
Clindamycin Hcl Generic 11 $6

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$73,109

Medicare's payments for the services billed

Medicare patients

223

Average age 76

Services billed

668

149 women, 74 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Chronic kidney disease 40%
Depression 34%
Ischemic heart disease 30%
Diabetes 27%
COPD 27%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

186 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record